In vivo assessment of growth and virulence gene expression during commensal and pathogenic lifestyles of luxABCDE-tagged Enterococcus faecalis strains in murine gastrointestinal and intravenous infection models

Applied and Environmental Microbiology

Volumn 79, Issue 13, 2013, Pages 3986-3997

  La Rosa, Sabina Leanti ^a   Casey, Pat G ^b,c   Hill, Colin ^b,c   Diep, Dzung B ^a   Nes, Ingolf F ^a   Brede, Dag A ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLUMINESCENCE IMAGING; DIFFERENTIAL REGULATION; ENTEROCOCCUS FAECALIS; EXPRESSION LEVELS; EXPRESSION PROFILE; GALLERIA MELLONELLA; GASTROINTESTINAL TRACT; INFECTION MODELS;

BIOLUMINESCENCE; GENE EXPRESSION; MAMMALS; PHOSPHORESCENCE; PLANTS (BOTANY);

BACILLI;

GELATINASE; PERFORIN; PRIMER DNA; STREPTOMYCIN;

ANTIBIOTICS; BACTERIUM; CATERPILLAR; DIGESTIVE SYSTEM DISORDER; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH RATE; MOTH; PATHOGENICITY; PEPTIDE; RODENT; VIRULENCE;

ANIMAL; ARTICLE; BACTERIAL COUNT; BAGG ALBINO MOUSE; BLADDER; C57BL MOUSE; ENTEROCOCCUS FAECALIS; FECES; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETICS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; KIDNEY; LIVER; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOTH; MOUSE; PATHOGENICITY; PROMOTER REGION; VIRULENCE;

ANIMALS; COLONY COUNT, MICROBIAL; DNA PRIMERS; ENTEROCOCCUS FAECALIS; FECES; FEMALE; GASTROINTESTINAL TRACT; GELATINASES; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MOTHS; PERFORIN; PROMOTER REGIONS, GENETIC; STREPTOMYCIN; URINARY BLADDER; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; GALLERIA MELLONELLA; MURINAE; MUS;

EID: 84879834054     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00831-13     Document Type: Article

References (48)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309 -317.
2. Sava IG, Heikens E, Huebner J. 2010. Pathogenesis and immunity in enterococcal infections. Clin. Microbiol. Infect. 16:533-540.
3. Coburn PS, Gilmore MS. 2003. The Enterococcus faecalis cytolysin: a novel toxin active against eukaryotic and prokaryotic cells. Cell. Microbiol. 5:661- 669.
4. Mylonakis E, Engelbert M, Qin X, Sifri CD, Murray BE, Ausubel FM, Gilmore MS, Calderwood SB. 2002. The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect. Immun. 70:4678- 4681.
5. Shankar N, Coburn P, Pillar C, Haas W, Gilmore M. 2004. Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island. Int. J. Med. Microbiol. 293:609-618.
6. Haas W, Shepard BD, Gilmore MS. 2002. Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 415:84-87.
7. Qin X, Singh KV, Weinstock GM, Murray BE. 2001. Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J. Bacteriol. 183:3372-3382.
8. Foucault ML, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C. 2010. In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Appl. Environ. Microbiol. 76:264- 274.
9. Bron PA, Monk IR, Corr SC, Hill C, Gahan CG. 2006. Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes. Appl. Environ. Microbiol. 72: 2876-2884.
10. Riedel CU, Monk IR, Casey PG, Morrissey D, O'Sullivan GC, Tangney M, Hill C, Gahan CG. 2007. Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl. Environ. Microbiol. 73:3091-3094.
11. Monack DM, Bouley DM, Falkow S. 2004. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1/mice and can be reactivated by IFNgamma neutralization. J. Exp. Med. 199:231-241.
12. Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, Contag PR. 2000. Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect. Immun. 68:3594 -3600.
13. Watson D, Sleator RD, Casey PG, Hill C, Gahan CG. 2009. Specific osmolyte transporters mediate bile tolerance in Listeria monocytogenes. Infect. Immun. 77:4895- 4904.
14. La Rosa SL, Diep DB, Nes IF, Brede DA. 2012. Construction and application of a luxABCDE reporter system for real-time monitoring of Enterococcus faecalis gene expression and growth. Appl. Environ. Microbiol. 78:7003-7011.
15. Huycke MM, Spiegel CA, Gilmore MS. 1991. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 35:1626 -1634.
16. Brede DA, Snipen LG, Ussery DW, Nederbragt AJ, Nes IF. 2011. Complete genome sequence of the commensal Enterococcus faecalis 62, isolated from a healthy Norwegian infant. J. Bacteriol. 193:2377-2378.
17. Jacob AE, Hobbs SJ. 1974. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117:360 -372.
18. LeBlanc DJ, Lee LN. 1982. Characterization of two tetracycline resistance determinants in Streptococcus faecalis JH1. J. Bacteriol. 150:835- 843.
19. Myhal ML, Laux DC, Cohen PS. 1982. Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur. J. Clin. Microbiol. 1:186 -192.
20. Que JU, Hentges DJ. 1985. Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice. Infect. Immun. 48:169 -174.
21. Solheim M, Aakra A, Snipen LG, Brede DA, Nes IF. 2009. Comparative genomics of Enterococcus faecalis from healthy Norwegian infants. BMC Genomics 10:194. doi:10.1186/1471-2164-10-194.
22. Grady R, Hayes F. 2003. Axe-Txe, a broad-spectrum proteic toxinantitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol. Microbiol. 47:1419 -1432.
23. Holo H, Nes IF. 1989. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55:3119 -3123.
24. Michaux C, Sanguinetti M, Reffuveille F, Auffray Y, Posteraro B, Gilmore MS, Hartke A, Giard JC. 2011. SlyA is a transcriptional regulator involved in the virulence of Enterococcus faecalis. Infect. Immun. 79:2638- 2645.
25. Gaspar F, Teixeira N, Rigottier-Gois L, Marujo P, Nielsen-LeRoux C, Crespo MTB, Lopes MSF, Serror P. 2009. Virulence of Enterococcus faecalis dairy strains in an insect model: the role of fsrB and gelE. Microbiology 155:3564 -3571.
26. Benachour A, Ladjouzi R, Le Jeune A, Hebert L, Thorpe S, Courtin P, Chapot-Chartier MP, Prajsnar TK, Foster SJ, Mesnage S. 2012. The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence. J. Bacteriol. 194: 6066-6073.
27. Joyce SA, Gahan CG. 2010. Molecular pathogenesis of Listeria monocytogenes in the alternative model host Galleria mellonella. Microbiology 156:3456 -3468.
28. Bohnhoff M, Drake BL, Miller CP. 1954. Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86:132-137.
29. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804-807.
30. Gilmore MS, Ferretti JJ. 2003. Microbiology. The thin line between gut commensal and pathogen. Science 299:1999 -2002.
31. Solheim M, Brekke MC, Snipen LG, Willems RJ, Nes IF, Brede DA. 2011. Comparative genomic analysis reveals significant enrichment of mobile genetic elements and genes encoding surface structure-proteins in hospital-associated clonal complex 2 Enterococcus faecalis. BMC Microbiol. 11:3. doi:10.1186/1471-2180-11-3.
32. Gahan CG. 2012. The bacterial lux reporter system: applications in bacterial localisation studies. Curr. Gene Ther. 12:12-19.
33. Nakayama J, Cao Y, Horii T, Sakuda S, Nagasawa H. 2001. Chemical synthesis and biological activity of the gelatinase biosynthesis-activating pheromone of Enterococcus faecalis and its analogs. Biosci. Biotechnol. Biochem. 65:2322-2325.
34. Park SY, Kim KM, Lee JH, Seo SJ, Lee IH. 2007. Extracellular gelatinase of Enterococcus faecalis destroys a defense system in insect hemolymph and human serum. Infect. Immun. 75:1861-1869.
35. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. 2006. Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. U. S. A. 103:10414 -10419.
36. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. 2001. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. U. S. A. 98:10892- 10897.
37. Nakayama J, Cao Y, Horii T, Sakuda S, Akkermans AD, de Vos WM, Nagasawa H. 2001. Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol. Microbiol. 41:145-154.
38. Daniel C, Poiret S, Dennin V, Boutillier D, Pot B. 2013. Biolumines- cence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Appl. Environ. Microbiol. 79:1086 -1094.
39. Husebye E. 2005. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 51(Suppl 1):1-22.
40. Vebo HC, Solheim M, Snipen L, Nes IF, Brede DA. 2010. Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine. PLoS One 5:e12489. doi:10.1371/journal.pone.0012489.
41. Shankar N, Baghdayan AS, Gilmore MS. 2002. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature 417:746 -750.
42. Hoffmann M, Messlik A, Kim SC, Sartor RB, Haller D. 2011. Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis. Mol. Nutr. Food Res. 55:703-713.
43. Hoffmann M, Kim SC, Sartor RB, Haller D. 2009. Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis. J. Proteome Res. 8:1183-1192.
44. Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, Vogelmann R, Schemann M, Kuster B, Sartor RB, Haller D. 2011. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141:959 -971.
45. Huycke MM, Joyce WA, Gilmore MS. 1995. Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice. J. Infect. Dis. 172:273-276.
46. Miyazaki S, Fujikawa T, Kobayashi I, Matsumoto T, Tateda K, Yamaguchi K. 2001. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J. Med. Microbiol. 50: 695-701.
47. Malani PN, Thal L, Donabedian SM, Robinson-Dunn B, Kauffman CA, Chow JW, Hershberger E, Zervos MJ. 2002. Molecular analysis of vancomycin- resistant Enterococcus faecalis from Michigan hospitals during a 10 year period. J. Antimicrob. Chemother. 49:841- 843.
48. Gentry-Weeks C, Estay M, Loui C, Baker D. 2003. Intravenous mouse infection model for studying the pathology of Enterococcus faecalis infections. Infect. Immun. 71:1434 -1441.